Nurix Stock Story

Nurix Stock News module provides quick insight into current market opportunities from investing in Nurix Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Nurix Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out Stocks Correlation.
  
Refresh
Nurix Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nurix daily returns and investor perception about the current pice of Nurix Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Van Houte Hans of 46177 shares of Nurix Therapeutics subject to Rule 16b-3
Filed transaction by Nurix Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Nurix insider trading alert for grant of restricted stock units by Van Houte Hans, Chief Financial Officer, on 21st of January 2022. This event was filed by Nurix Therapeutics Inc with SEC on 2022-01-21. Statement of changes in beneficial ownership - SEC Form 4
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Nurix Therapeutics Fundamental Analysis

We analyze Nurix Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nurix Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nurix Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Peers

Your Trending Equities

AAL  7.67   
0%
100.0%
C  7.56   
0%
98.0%
AA  5.18   
0%
67.0%
WFC  3.55   
0%
46.0%
INTC  3.06   
0%
39.0%
AAPL  2.54   
0%
33.0%
IBM  2.47   
0%
32.0%
S  2.41   
0%
31.0%
MET  2.15   
0%
28.0%
UPS  1.87   
0%
24.0%
HD  1.68   
0%
21.0%
T  1.43   
0%
18.0%
CVS  0.84   
0%
10.0%
CVX  0.59   
0%
7.0%
BBY  0.32   
4.0%
0%
TGT  1.81   
23.0%
0%
Check out Stocks Correlation. Note that the Nurix Therapeutics information on this page should be used as a complementary analysis to other Nurix Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Tools for Nurix Stock

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go